Does Blue Cross Blue Shield Cover Emgality?
The verdict
Covered on most plans
BCBS plans broadly cover Emgality for migraine prevention, but prior authorization and step therapy are required — you must typically document failure of 2 or more oral migraine preventives (such as topiramate or propranolol) and 4 or more migraine days per month. Because BCBS is 30-plus independent licensees, tier placement and PA specifics vary by state plan. About 60% of Medicare enrollees have brand Emgality access. Verify on your state BCBS formulary.
Coverage is set by your specific plan and formulary. This is a research summary — always confirm with Blue Cross Blue Shield using your member ID.
Key facts
Medicare covers Emgality for only about 60% of enrollees — the lowest access rate among payer channels — with most requiring prior authorization.
GoodRx/MMIT formulary access data, February 2025
BCBS is 30-plus independent licensees; tier placement, PBM, and step-therapy sequence for Emgality vary by state plan — there is no single national BCBS policy.
BCBS Association / state licensee formularies
The Emgality Savings Card can reduce commercial cost to as little as $35/month; it is not available for Medicare or Medicaid members.
Eli Lilly Emgality savings program
Medicare vs. commercial coverage
Whether Blue Cross Blue Shield covers Emgality depends heavily on which kind of plan you hold. They follow completely different rules — here's each one, side by side.
Medicare
Part D & Advantage plans
Medicare Part D (BCBS MA-PD plans): approximately 60% of Medicare enrollees have access to brand Emgality, with most requiring PA per GoodRx/MMIT data (February 2025). Medicare offers less Emgality access than commercial or Medicaid channels. Coinsurance is typically 25–33% after the deductible. The 2026 Part D out-of-pocket cap of $2,100 limits annual exposure. The Emgality Savings Card is not available to Medicare beneficiaries. Step-therapy and formulary specifics vary by BCBS MA-PD plan — verify on your plan drug list.
Commercial / Employer
Group & marketplace plans
Commercial/Employer: Emgality is covered on the specialty or Tier 3 with PA and step therapy. The real gate is step therapy: most BCBS plans require documented failure of at least 2 oral preventives (topiramate, propranolol, amitriptyline or similar) and documentation of 4 or more migraine days per month before Emgality is approved. Tier and PBM vary across 30-plus BCBS licensees — verify on your state BCBS formulary. The Emgality Savings Card can reduce commercial cost to as little as $35 or $0. ACA/Individual: specialty or Tier 3 with PA where offered. Medicaid (BCBS-managed): covered per state PDL with PA; broader access but 60-plus percent require PA and step therapy; nominal cost-share.
The 5 boxes you must tick to get approved
Commercial plans that will consider Emgality require prior authorization. Check off what applies to you to see how close you are — this is a guide, not a guarantee of approval.
Meet all 5 and you have a documented case for approval. Missing any one is the most common reason requests are denied.
Your cost, three ways
What Emgality actually costs you swings enormously depending on how it's covered. Here's the realistic range.
Paying cash
Cash price approximately $650–$800/month (list/WAC estimate); SingleCare reports approximately $981 for a single 120 mg pen. Treat as an estimate — verify with pharmacy.
List price with no coverage — before any manufacturer savings card.
With coverage
Commercial: specialty or Tier 3 coinsurance varies by BCBS licensee; the Emgality Savings Card can reduce cost to as little as $35 (some sources $0) for eligible commercially insured patients. Medicare Part D: typically 25–33% coinsurance after the deductible, capped at $2,100 for the year (2026 cap). Medicaid: nominal cost-share per state plan.
Typical monthly copay once prior authorization is approved.
Bridge program
Emgality Savings Card: as little as $35/month (some sources report $0) for eligible commercially insured patients. Not available to Medicare or Medicaid beneficiaries. Contact Eli Lilly or visit emgality.com to enroll.
Reduced copay through the assistance program, where eligible.
All figures are estimates. Coinsurance varies by BCBS licensee and specific plan tier. Confirm your cost-share with your state BCBS plan before filling.
Check YOUR exact coverage in 3 steps
General answers only get you so far. Here's how to confirm your own plan's decision in a few minutes.
- 1
Find your specific state BCBS formulary
There is no single national BCBS Emgality policy — each of the 30-plus BCBS licensees has its own formulary and PA criteria. Go to your state BCBS plan's website (e.g., bcbsil.com, bcbsnc.com, blueshieldca.com) and use the drug or formulary lookup tool to search for 'galcanezumab' or 'Emgality' on your specific plan.
- 2
Confirm step-therapy requirements with your neurologist
Before applying for PA, verify with your treating neurologist or headache specialist which oral preventives you have already tried and failed. You will need documentation of at least 2 prior oral preventives (and failure due to inefficacy or side effects) and your migraine frequency to satisfy step-therapy requirements.
- 3
Have your specialist submit the prior authorization
Ask your neurologist or headache specialist to initiate the PA request through your state BCBS plan. The submission should include diagnosis, migraine frequency, prior-treatment history, and clinical rationale. Ask about the specific specialty pharmacy your plan requires for Emgality dispensing.
Options if Blue Cross Blue Shield won't cover Emgality
A denial isn't the end of the road. These are the paths people commonly explore next — discuss any of them with your prescriber.
Aimovig (erenumab)
Another CGRP inhibitor for migraine prevention. May carry a different formulary tier on your BCBS plan — check your state BCBS formulary to compare placement and step-therapy requirements.
Ajovy (fremanezumab)
A third CGRP inhibitor for migraine prevention. May be preferred on some BCBS licensee formularies. Check your state plan's drug list for tier and PA requirements.
Oral preventive therapies
Topiramate, propranolol, amitriptyline, and valproate are typically Tier 1 or 2 generics on BCBS plans and covered with minimal PA.
These options are listed for information only — your own clinician decides what is appropriate for you.
❓Frequently Asked Questions
BCBS plans, like most insurers, apply step therapy for CGRP inhibitors because generic oral preventives such as topiramate, propranolol, and amitriptyline are far less expensive and effective for many patients. Most licensees require documented failure of at least 2 oral agents — due to inadequate efficacy or side effects — and 4 or more migraine days per month before approving a biologic preventive like Emgality. Once you document those failures, PA approval is generally achievable.
No. BCBS is 30-plus independent licensees, each with its own formulary, PBM, and PA criteria. The step-therapy requirement (2+ failed oral preventives) and migraine-frequency threshold (4+ migraine days/month) are broadly consistent across the industry, but the exact formulary tier, specialty pharmacy, and step-therapy sequence differ by state plan. Always verify on your specific state BCBS formulary — not a national BCBS page.
Access is more limited on Medicare than on commercial plans. About 60% of Medicare enrollees have brand Emgality access, with most requiring PA, per GoodRx/MMIT data from February 2025. If your BCBS Medicare Advantage or Part D plan covers it, expect specialty-tier coinsurance of 25–33%, capped at $2,100 for the year (2026 Part D cap). The Emgality Savings Card is not available to Medicare beneficiaries.
Yes, if you have commercial BCBS insurance. The Emgality Savings Card from Eli Lilly can reduce your out-of-pocket cost to as little as $35/month (some sources report $0) for eligible commercially insured patients. The card is not available to Medicare, Medicaid, or other government-plan members. Visit emgality.com to check eligibility and enroll.
Coverage varies by state licensee — there is no single best BCBS plan for Emgality. Factors that matter include formulary tier (specialty vs. Tier 3), PBM (Prime Therapeutics, CVS Caremark, or others), step-therapy sequence, and your plan-specific coinsurance. Some BCBS ACA marketplace plans include robust migraine-biologic coverage. Review your specific state BCBS formulary and compare CGRP inhibitors (Emgality, Aimovig, Ajovy) to find the preferred option on your plan.
Related Articles
Does BCBS Michigan Cover Contrave? 2026 MI Guide | Curex
BCBS Michigan upheld weight-loss exclusions (DIFS 2025). Contrave is plan-dependent. MI Medicaid favors weight-loss GLP-1s; Contrave varies by PDL.
Read moreDoes BCBS of Illinois Cover Jardiance? 2026
BCBS of Illinois (HCSC) covers Jardiance across commercial, ACA, Medicare, and Medicaid. Metformin-first step is common. 2026 MFP $197 for Medicare.
Read moreDoes BCBS Alabama Cover Wegovy? 2026 Guide | Curex
BCBS Alabama Wegovy coverage is employer-dependent and unpublished. Alabama Medicaid excludes obesity GLP-1s. How to verify your specific plan.
Read moreDoes Blue Cross Blue Shield of Minnesota Cover Mounjaro? 2026 | Curex
BCBS of Minnesota covers Mounjaro for type 2 diabetes with PA — not weight loss. MN Medicaid covers weight-loss GLP-1s for Zepbound, not Mounjaro.
Read moreDoes Blue Cross Blue Shield Cover Ambien? 2026 | Curex
Blue Cross Blue Shield covers generic zolpidem (Tier 1–2); brand Ambien is non-preferred. Quantity limits apply. Verify your specific BCBS plan for 2026.
Read moreDoes BCBS of Texas Cover Ozempic? 2026 Guide | Curex
BCBS Texas (HCSC) covers Ozempic for T2D with PA — not weight loss. HCSC shares PA with BCBS IL. TX Medicaid uses separate Star MCOs. Verify on BCBS TX.
Read moreThis content is for informational purposes only and does not constitute medical, financial, or insurance advice. Coverage rules, prior-authorization criteria, and copay amounts change frequently and vary by plan, formulary tier, and effective date — always verify current benefits directly with Blue Cross Blue Shield before making any decision. Consult a licensed healthcare provider and your plan administrator for guidance specific to your situation.